Novel reaction to new cystic fibrosis medication Trikafta

We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginni...

Descripción completa

Detalles Bibliográficos
Autores principales: Stashower, Julian, Carr, Patrick, Miller, Virginia, Zlotoff, Barrett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122137/
https://www.ncbi.nlm.nih.gov/pubmed/34026156
http://dx.doi.org/10.1002/ccr3.4116
Descripción
Sumario:We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.

Ejemplares similares